Alloimmunization is diagnosed through blood tests that identify the presence of alloantibodies. These tests include the indirect Coombs test, also known as the indirect antiglobulin test (IAT), which detects antibodies in the serum. For pregnant women, regular antibody screening is part of prenatal care to monitor for any development of alloantibodies.
